Treatment of type IIa, IIb, III, IV and V hyperlipoproteinemias. It reduces elevated plasma concentrations of triglycerides by reducing the concentration of very low-density lipoprotein. It reduces elevated plasma concentrations of cholesterol to a lesser extent but the effect is variable.